Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page
- Check2 days agoChange DetectedA new page revision, v3.5.2, was added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe related topics section at the bottom, including 'Prostate Cancer' and the 'MedlinePlus Genetics', was removed.SummaryDifference0.2%

- Check23 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to the page. This enhances access to disease- and genetics-related information without changing the core study details.SummaryDifference0.2%

- Check31 days agoChange DetectedRevision: v3.5.0 was added. A related topics entry for Prostate cancer: MedlinePlus Genetics was removed (including its Revision: v3.4.3).SummaryDifference0.2%

- Check38 days agoChange DetectedAdded related topics Prostate cancer and MedlinePlus Genetics, and updated the site revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check66 days agoChange DetectedA new revision label v3.4.2 has been added. The previously displayed government funding status notice (and the earlier v3.4.1 revision) has been removed.SummaryDifference0.5%

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.